AVI (AVI) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
3 Feb, 2026Executive summary
Delivered sound performance with group revenue up 1% and operating profit up 7.8% year-over-year, despite weak demand and supply chain challenges.
Gross profit margin improved to 42.7%, and headline earnings per share rose 6.1% to 729.1 cents.
Sustained strong cash flow generation and high return on capital employed at 34.9%.
R42 million invested in restructuring to drive future value.
ZAR 5 billion returned to shareholders over two years, including special dividends.
Financial highlights
Revenue: R16,021.5m (+1.0% YoY); Operating profit: R3,561.9m (+7.8% YoY); Net financing cost increased 22.9%.
Gross profit: R6,837.5m (+3.4% YoY); Gross margin: 42.7% (+2.4pp YoY).
Headline earnings: R2,418.2m (+6.4% YoY); HEPS: 729.1c (+6.1% YoY).
Final dividend: 406c/share; total normal dividend: 626c/share (+6.1% YoY); special dividend paid in October 2024.
Dividend yield: 6.7% at year-end share price.
Outlook and guidance
Anticipates margin benefits from hedging and restructuring in FY 2026.
Ongoing price/volume management and cost control essential to protect margins.
I&J's outlook depends on fishing, fuel prices, and exchange rates; abalone recovery remains uncertain.
Innovation in smaller, affordable formats and health-focused products to drive growth.
Planned capital expenditure of R425m in F26 to support innovation and operational upgrades.
Latest events from AVI
- Operating profit rose 11.6% on 4.9% revenue growth, with margins and cash flow both improving.AVI
H1 20269 Mar 2026 - Operating profit up 8.9% with margin gains, but demand and cost headwinds persist.AVI
H1 20253 Feb 2026 - Headline earnings per share expected to rise up to 12.5% on 4.9% revenue growth and margin gains.AVI
H1 2026 TU27 Jan 2026 - Operating profit up 21.7% and headline EPS up 24.1% on strong cost control and cash flow.AVI
H2 202421 Jan 2026